Capsular polysaccharide correlates with immune response to the human gut microbe Ruminococcus gnavus

Area of Science:

• Microbiology
• Immunology
• Gastroenterology

Background:

• Active inflammatory bowel disease (IBD) is often associated with increased levels of the gut microbe Ruminococcus gnavus.
• The precise mechanisms linking R. gnavus to IBD pathogenesis remained unclear.

Purpose of the Study:

• To investigate the molecular mechanisms by which R. gnavus contributes to inflammation in IBD.
• To determine if specific R. gnavus strains or their products influence immune responses relevant to IBD.

Main Methods:

• Analysis of clinical isolates of R. gnavus for the presence of a capsule.
• In vitro assessment of immune responses to encapsulated and non-encapsulated R. gnavus isolates.
• Colonization of germ-free mice with different R. gnavus isolates to evaluate gut inflammation in vivo.

Main Results:

• Some R. gnavus isolates produce a capsular polysaccharide that induces a tolerogenic immune response.
• Isolates lacking functional capsule biosynthesis genes elicit strong proinflammatory responses in vitro.
• Mice colonized with non-encapsulated R. gnavus showed increased gut inflammation compared to those with encapsulated strains.

Conclusions:

• The presence or absence of a capsule in R. gnavus strains significantly impacts host immune responses.
• Non-encapsulated R. gnavus strains may drive inflammatory responses characteristic of IBD.
• These findings elucidate a mechanism by which specific gut microbes contribute to inflammatory bowel disease.